More Games With U.S. Insulin Prices and Coupons (or why GoodRx works)
This week, I did something unplanned: I bought a vial of Lilly ' s " authorized generic " of its brand-name U-100 insulin analog usually branded as Humalog (insulin lispro rDNA origin) at my neighborhood Walgreens for just $68.38. The reason it was unplanned is because I already met the deductible for my insurance plan, so I hadn ' t expected to deal with this until it resets in January (maybe, I think my new plan covers it without having met the deductible but we ' ll see). But I had a script I last filled before I met the deductible, and the pharmacy sent a text telling me it was time to refill. In reality, I have insuli...
Source: Scott's Web Log - September 23, 2020 Category: Endocrinology Tags: Admelog Drug Channels drug prices GoodRx Humalog insulin Lilly lispro prescriptions rebates Sanofi Walgreens Source Type: blogs
Insulin in the Human Body
You're reading Insulin in the Human Body, originally posted on Pick the Brain | Motivation and Self Improvement. If you're enjoying this, please visit our site for more inspirational articles.
What is insulin?
To do the tasks, the body needs energy and sugar can be considered a good source of energy to be obtained from inside. As a matter of fact, sugar cannot be directly reached to most of your cells. Thus, there are cells emitted from the pancreas, which will release the sugar in the human body which is termed as insulin.
Insulin is a hormone that is secreted by the pancreas that is responsible for the regulation ...
Source: PickTheBrain | Motivation and Self Improvement - August 2, 2019 Category: Consumer Health News Authors: Chandan Singh Tags: health and fitness Source Type: blogs
Why you shouldn ’t be happy with $137 insulin
Eli Lilly and Co. recently announced with some fanfare that it was manufacturing a generic version of its own best-selling insulin brand, Humalog, which it would sell for half off — $137.35 versus about $275. David Ricks, the chief executive of Lilly, said the company was making this seemingly beneficent gesture because “many patients are […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - June 13, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/elisabeth-rosenthal" rel="tag" > Elisabeth Rosenthal, MD < /a > < /span > Tags: Meds Diabetes Endocrinology Source Type: blogs
Human insulin may be a lower-cost option for some people with diabetes
Of the estimated 23 million people in the US who have been diagnosed with diabetes, more than 30% take daily insulin injections to control their blood sugar (glucose) levels. Chances are good that someone you know has been startled by the high cost of this medication.
The high price of insulin
Prices for this essential medication have been rising faster than overall health care costs. From 2002 to 2013 prices tripled, doubling again from 2012 to 2016 and continuing upward since. Patients can be charged hundreds or even thousands of dollars for insulin at the pharmacy. And insulin costs can vary depending on type and amount...
Source: Harvard Health Blog - June 3, 2019 Category: Consumer Health News Authors: Elizabeth Bashoff, MD Tags: Diabetes Drugs and Supplements Health Source Type: blogs
My Trial With Sanofi's Admelog, The Biosimilar Version of Humalog
A while back Iblogged about the emergence of biosimilar insulin in the U.S., more than a decade after I studied the topic and discovered some troubling reasons none existed. Since then, in spite of top officials at the U.S. Department of Health and Human Services advocating for a more robust biosimilars market in the U.S., we have seen fewer rather than more, so that ' s not working out so well for the Trump Administration ' s promise to bring drug prices way down so far. In late 2018, Merck quietly pulled the plug on its own Lantus biosimilar which was to be branded as Lusduna Nexvue (see moreHERE for details). ...
Source: Scott's Web Log - April 9, 2019 Category: Endocrinology Tags: Eli Lilly and Company follow-on insulin analogs 2019 Admelog biosimilars generics Humalog insulin prices Medicare Sanofi Source Type: blogs
My Trial With Sanofi's Admelog, The Biosimilar Version of Humalog
A while back Iblogged about the emergence of biosimilar insulin in the U.S., more than a decade after I studied the topic and discovered some troubling reasons none existed. Since then, in spite of top officials at the U.S. Department of Health and Human Services advocating for a more robust biosimilars market in the U.S., we have seen fewer rather than more, so that ' s not working out so well for the Trump Administration ' s promise to bring drug prices way down so far. In late 2018, Merck quietly pulled the plug on its own Lantus biosimilar which was to be branded as Lusduna Nexvue (see moreHERE for details). ...
Source: Scott's Web Log - April 9, 2019 Category: Endocrinology Tags: Eli Lilly and Company follow-on insulin analogs 2019 Admelog biosimilars generics Humalog insulin prices Medicare Sanofi Source Type: blogs
Your Questions Answered on Lilly's New 50% Cheaper Insulin Lispro
DiabetesMine investigates Eli Lilly ' s plans to introduce an " authorized generic " form of its Humalog insulin called Lispro, that will cost 50% less. (Source: Diabetes Mine)
Source: Diabetes Mine - March 7, 2019 Category: Endocrinology Authors: Mike Hoskins and Amy Tenderich Source Type: blogs
MKSAP: 25-year-old woman with type 1 diabetes mellitus
Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians.
A 25-year-old woman with type 1 diabetes mellitus is evaluated for recent-onset glycemic fluctuations without symptomatic hypoglycemia. She was diagnosed with diabetes 7 years ago. Her HbA1c levels since diagnosis have ranged from 6.4% to 7.3%, with the most recent value at 7.3%. She reports eating a carbohydrate-consistent diet at each meal, with little variation in her selection of meals or snacks. She started a new job several months ago but continues her daily exercise routine and sleep schedule. She has no ...
Source: Kevin, M.D. - Medical Weblog - September 22, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/mksap" rel="tag" > mksap < /a > Tags: Conditions Diabetes Endocrinology Source Type: blogs
A Decade+ Later, Biosimilar Insulin Is Here
More than a decade ago (the article I published on my blog was originally posted on January 8, 2007 although I began research into the subject the preceding summer, see the article athttp://blog.sstrumello.com/2007/01/business-of-diabetes-real-story-behind.html for more background), I asked a number of very legitimate questions (some of which were later answered, others were not), with the most notable one being about why so many other diabetes medicines had " generics " but insulin did not (in spite of the fact that its patents had expired years ago). Unfortunately, in my research, I discovered the some of the sordi...
Source: Scott's Web Log - April 21, 2018 Category: Endocrinology Tags: insulin analogs 2018 biogenerics biosimilars Source Type: blogs
A Decade+ Later, Biosimilar Insulin Is Here
More than a decade ago (the article I published on my blog was originally posted on January 8, 2007 although I began research into the subject the preceding summer, see the article athttp://blog.sstrumello.com/2007/01/business-of-diabetes-real-story-behind.html for more background), I asked a number of very legitimate questions (some of which were later answered, others were not), with the most notable one being about why so many other diabetes medicines had " generics " but insulin did not (in spite of the fact that its patents had expired years ago). Unfortunately, in my research, I discovered the some of the sordi...
Source: Scott's Web Log - April 21, 2018 Category: Endocrinology Tags: insulin analogs 2018 biogenerics biosimilars Source Type: blogs
MKSAP: 25-year-old woman with type 1 diabetes
Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians.
A 25-year-old woman with type 1 diabetes presents to clinic requesting more information about use of a closed-loop insulin-delivery system (artificial beta cell).
Although her HbA1c is at goal, she notes frequent hypoglycemia as an issue. In addition, she would like to further improve her glycemic control in anticipation of pregnancy in the next few years. Her father also has type 1 diabetes managed on insulin pump therapy. Her only medication is insulin lispro administered through a sensor-augmented insulin pum...
Source: Kevin, M.D. - Medical Weblog - July 22, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/mksap" rel="tag" > mksap < /a > Tags: Conditions Diabetes Endocrinology Source Type: blogs
MKSAP: 68-year-old man with a right intertrochanteric fracture
Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians.
A 68-year-old man is evaluated in the hospital for a right intertrochanteric fracture sustained in a mechanical fall. He reports right hip pain but no other symptoms. He has hypertension and type 2 diabetes mellitus and was in his usual state of health prior to the fall. He checks his blood glucose level several times daily; his average blood glucose level is 150 mg/dL (8.3 mmol/L), with a low of 92 mg/dL (5.1 mmol/L) and a high of 208 mg/dL (11.5 mmol/L). Surgical repair is scheduled for tomorrow at 7 a.m. with...
Source: Kevin, M.D. - Medical Weblog - January 28, 2017 Category: Journals (General) Authors: < a href="http://www.kevinmd.com/blog/post-author/mksap" rel="tag" > mksap < /a > Tags: Conditions Diabetes Orthopedics Source Type: blogs
Skyrocketing prescription prices force patients to skip meds
This article is adapted from the AAFP Leader Voices Blog.
Image credit: Shutterstock.com
Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - November 10, 2016 Category: Journals (General) Authors: < a href="http://www.kevinmd.com/blog/post-author/michael-munger" rel="tag" > Michael Munger, MD < /a > Tags: Meds Medications Source Type: blogs
The Business of Diabetes: CVS Caremark's Salvo in Biosimilar Insulin for 2017
Its already mid-2016, and for nearly the past decade, I ' ve been pushing for so-called " biosimilars " or " follow-on biologics " like insulin to be legalized and then introduced in the U.S. (I first investigated this issue back in 2006, and published anarticle on it in January 2007). The reality is that without any form of generic competition, prices continue to rise with absolutely nothing to stop them. In recent years, there have been some hyper-aggressive price-increases from the insulin oligopoly, especially within the last 3 years or so. The reason: they all KNOW that their insulin analog patents are about...
Source: Scott's Web Log - August 5, 2016 Category: Endocrinology Tags: Biosimilar insulin Lantus Lilly Merck Source Type: blogs
The Business of Diabetes: CVS Caremark's Salvo in Biosimilar Insulin for 2017
Its already mid-2016, for nearly the past decade, I ' ve been pushing for so-called " biosimilars " or " follow-on biologics " like insulin to be legalized and then introduced in the U.S. (I first investigated this issue back in 2006, and published anarticle on it in January 2007). The reality is that without any form of generic competition, prices continue to rise with absolutely nothing to stop them. In recent years, there have been some hyper-aggressive price-increases from the insulin oligopoly, especially within the last 3 years or so. The reason: they all KNOW that their insulin analog patents are about to ...
Source: Scott's Web Log - August 5, 2016 Category: Endocrinology Tags: Biosimilar insulin Lantus Lilly Merck Source Type: blogs
